Literature DB >> 6613840

Efficacy and safety of long-term amiodarone in treatment of cardiac arrhythmias: dosage experience.

C I Haffajee, J C Love, J S Alpert, G K Asdourian, K C Sloan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6613840     DOI： 10.1016/0002-8703(83)90019-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  12 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Comparative hemodynamics of antiarrhythmic drugs.

Authors:  M Sami
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

3.  Amiodarone. Biochemical aspects and haemodynamic effects.

Authors:  J P Gagnol; C Devos; M Clinet; P Nokin
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

4.  Relationship between preoperative amiodarone treatment and complications observed during anaesthesia for valvular cardiac surgery.

Authors:  D Chassard; M George; M Guiraud; J J Lehot; O Bastien; C Hercule; J Villard; S Estanove
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

5.  The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone.

Authors:  Jakob Gierten; Eckhard Ficker; Ramona Bloehs; Patrick A Schweizer; Edgar Zitron; Eberhard Scholz; Christoph Karle; Hugo A Katus; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-24       Impact factor: 3.000

6.  Haemodynamic effects of short term intravenous amiodarone for hypertrophic cardiomyopathy.

Authors:  A Branzi; C Rapezzi; P M Benenati; G Binetti; G Piovaccari; M Bacchi; R Roncuzzi; R Zannoli; B Magnani
Journal:  Br Heart J       Date:  1988-04

Review 7.  Clinical pharmacokinetics of the newer antiarrhythmic agents.

Authors:  A M Gillis; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

8.  Amiodarone in a newborn with ventricular tachycardia and an intracardiac tumor: adjusting the dose according to an individualized dosing regimen.

Authors:  T Bouillon; H Schiffmann; D Bartmus; U Gundert-Remy
Journal:  Pediatr Cardiol       Date:  1996 Mar-Apr       Impact factor: 1.655

9.  Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination.

Authors:  S Almog; N Shafran; H Halkin; P Weiss; Z Farfel; U Martinowitz; H Bank
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  Cardiovascular pharmacology of K2P17.1 (TASK-4, TALK-2) two-pore-domain K+ channels.

Authors:  Ingo Staudacher; Claudius Illg; Sam Chai; Isabelle Deschenes; Sebastian Seehausen; Dominik Gramlich; Mara Elena Müller; Teresa Wieder; Ann-Kathrin Rahm; Christina Mayer; Patrick A Schweizer; Hugo A Katus; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-14       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.